Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-03 Sale | 2023-01-05 9:42 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,834 | $55.98 | $886,407 | 243 (Direct) | View |
| 2022-12-01 Sale | 2022-12-02 9:30 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,834 | $61.6 | $975,406 | 16,077 (Direct) | View |
| 2022-11-01 Sale | 2022-11-03 9:31 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,833 | $62.88 | $995,658 | 31,911 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 9:46 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,833 | $61.52 | $974,082 | 47,744 (Direct) | View |
| 2022-09-28 Sale | 2022-09-30 9:30 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 31,666 | $48.09 | $1,522,818 | 63,577 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-15 Option Award | 2024-05-17 4:38 pm | N/A 2034-05-15 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 9:31 pm | N/A 2033-05-17 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-05 9:42 pm | N/A N/A | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,834 | $6.41 | 243 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-05 9:42 pm | N/A 2023-01-29 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,834 | $0 | 243 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 9:30 pm | N/A N/A | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,834 | $6.41 | 16,077 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 9:30 pm | N/A 2023-01-29 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,834 | $0 | 16,077 (Direct) | View |
| 2022-11-01 Exercise | 2022-11-03 9:31 pm | N/A N/A | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,833 | $6.41 | 31,911 (Direct) | View |
| 2022-11-01 Exercise | 2022-11-03 9:31 pm | N/A 2023-01-29 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,833 | $0 | 31,911 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 9:46 pm | N/A N/A | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,833 | $6.41 | 47,744 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 9:46 pm | N/A 2023-01-29 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,833 | $0 | 47,744 (Direct) | View |
| 2022-09-28 Exercise | 2022-09-30 9:30 pm | N/A N/A | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 31,666 | $6.41 | 63,577 (Direct) | View |
| 2022-09-28 Exercise | 2022-09-30 9:30 pm | N/A 2023-01-29 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 31,666 | $0 | 63,577 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 8:04 pm | N/A 2032-06-27 | AMARIN CORP PLC | AMRN | Ekman Lars Director | 209,669 | $0 | 209,669 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:53 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director | 9,545 | $0 | 23,990 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-27 9:30 pm | N/A 2032-05-18 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chair of the Board | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:24 pm | N/A 2031-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director | 6,270 | $0 | 18,570 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 8:01 pm | N/A 2031-06-14 | AMARIN CORP PLC | AMRN | Ekman Lars Director | 86,506 | $0 | 86,506 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-21 5:03 pm | N/A 2031-05-19 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Chairman of the Board | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:43 pm | N/A 2025-05-22 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Director | 24,544 | $0 | 24,544 (Direct) | View |
| 2021-02-12 Disposition | 2021-02-17 6:43 pm | 2016-05-18 2025-05-22 | PROTHENA CORP PUBLIC LTD CO | PRTA | Ekman Lars Director | 42,000 | $0 | 24,544 (Direct) | View |
| 2020-07-13 Option Award | 2020-07-15 8:02 pm | N/A 2030-07-13 | AMARIN CORP PLC | AMRN | Ekman Lars Director | 65,441 | $0 | 65,441 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-30 1:11 pm | N/A 2030-06-26 | Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director | 6,800 | $0 | 16,550 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:37 pm | N/A 2030-05-20 | Prothena Corp plc | PRTA | Ekman Lars Chairman of the Board | 17,500 | $0 | 17,743 (Direct) | View |
| 2019-12-17 Equity Swap | 2019-12-17 4:40 pm | N/A N/A | Spark Therapeutics Inc. | ONCE | Ekman Lars Director | 3,000 | $114.5 | 0 (Direct) | View |
| 2019-12-17 Disposition | 2019-12-17 4:40 pm | N/A 2028-05-29 | Spark Therapeutics Inc. | ONCE | Ekman Lars Director | 51,203 | $0 | 0 (Direct) | View |